News

Health And Pharma3h
START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors
The START Center for Cancer Research dosed the first patient in Moderna’s Phase 1 trial of mRNA-4106, a multivalent ...
Health And Pharma9h
FDA Approves Emrelis as the First Targeted ADC for High c-Met Expressing Lung Cancer
The FDA granted accelerated approval to Emrelis (telisotuzumab vedotin-tllv), the first targeted therapy for previously ...
Health And Pharma23h
ONCOLife Announces Appointment of Dr. İlkiz Er Dağ as Project Director, Oncology Training Programs
ONCOLife is delighted to announce that Dr İlkiz Er Dağ, MD, MBA, has joined the company as Project Director for Oncology ...